AI-generated summary
The authors reviewed clinical studies of transcranial photobiomodulation for major depression and depressive symptoms linked to other diseases, calculating standardized effect sizes and describing the papers. They report the largest antidepressant effects in studies using pulsed light with high peak but low average irradiance over a large skin area. A single well-designed, sham-controlled trial found low irradiance over a small skin area ineffective for depression. The authors note that optimal parameters remain undetermined and that the included studies are highly heterogeneous.
- Who or what was studied
- Adults with major depressive disorder and depressive symptoms comorbid with other diseases
- Limits stated in the abstract
- The clinical studies reviewed are highly heterogeneous in stimulation parameters, and optimal dosimetry has not been established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Depression, Dosimetry, Transcranial photobiomodulation, Irradiance, Effect size, Dementia, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.